MedPath

Comparison genetic profiling between myelodysplastic syndrome (MDS) and pre-MDS

Recruiting
Conditions
The patients 18 years and older who were diagnosed with MDS or pre-MDS between and have next-generation sequencing (NGS) results.
Myelodysplastic syndrome ,pre-Myelodysplastic syndrome ,genetic mutation ,low-dose erythropoietin therapy
Registration Number
TCTR20240405004
Lead Sponsor
Siriraj Hospital Mahidol University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
328
Inclusion Criteria

1.Patients aged above 18 years.
2.Patients diagnosed with MDS or pre-MDS.
3. Patients with bone marrow study and next-generation sequencing (NGS) results

Exclusion Criteria

From the review bone marrow study, the result cannot be concluded to MDS or pre-MDS

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the genetic profiling between MDS and pre-MDS first visit To evaluate genetic mutations
Secondary Outcome Measures
NameTimeMethod
To evaluate factors associated with well response first visit Low-dose ESA less than 10,000 units/week in in pre-MDS patients
© Copyright 2025. All Rights Reserved by MedPath